Výsledky vyhledávání - "J. Maldonado-Cocco"

OP0034 IXEKIZUMAB IMPROVES SIGNS, SYMPTOMS, AND QUALITY OF LIFE IN PATIENTS WITH AXIAL SpA IRRESPECTIVE OF DISEASE DURATION: RESULTS FROM THE COAST-V, COAST-W AND COAST-X TRIALS

Autor: V. Navarro-Compán, J. D. Reveille, P. Rahman, J. Maldonado-Cocco, M. Magrey, R. Bolce, D. Sandoval, S. Y. Park, A. Kronbergs, M. Rudwaleit

Publikováno v: Annals of the Rheumatic Diseases. 81:24.1-25

BackgroundIxekizumab (IXE), a high-affinity monoclonal antibody selectively targeting interleukin-17A,1 has demonstrated superior efficacy to placebo (PBO) in the treatment of patients (pts) with radiographic axial spondyloarthritis (r-axSpA) (COAST-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7363c0e4f5dc3e73c842db057698410e
https://doi.org/10.1136/annrheumdis-2022-eular.164

Zobrazit plný text záznamu

Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study

Autor: Øystein Førre, Rene Westhovens, M Bell, O Bjorneboe, F Caeiro, K H Abeywickrama, George A W Bruyn, G Tate, P Bernhardt, J Maldonado-Cocco, P.L.C.M. van Riel, PP Tak, H Tannenbaum

Publikováno v: Annals of the Rheumatic Diseases, 67, 1090-5
Annals of the Rheumatic Diseases, 67, 8, pp. 1090-5
Annals of the rheumatic diseases, 67(8), 1090-1095. BMJ Publishing Group

Contains fulltext : 70343.pdf (Publisher’s version ) (Closed access) OBJECTIVES: Everolimus, a proliferation signal inhibitor with disease-modifying properties, may be useful in treating rheumatoid arthritis (RA). This proof-of-concept study assess

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20cd66f2b46982a5059aed43a19a59a2
https://doi.org/10.1136/ard.2007.078808

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

FRI0030 Treatment with etoricoxib (mk-0663), a cox-2 selective inhibitor, resulted in maintenance of clinical improvement in rheumatoid arthritis

Autor: S Mukhopadhyay, Sean P. Curtis, Barry J. Gertz, Jennifer Ng, J Maldonado-Cocco, BR Losada, AE Gallagher

Publikováno v: Speaker abstracts 2001.

Background Prostanoid synthesis is catalysed by two distinct cyclooxygenase (COX) isoforms; COX-1 (constitutive) and COX-2 (inducible). NSAIDs such as aspirin, ibuprofen and indomethacin inhibit both COX isoforms. Etoricoxib has been characterised as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::62b797377a8f817bf34f26ead36c292f
https://doi.org/10.1136/annrheumdis-2001.1159

Zobrazit plný text záznamu

[Efficacy, tolerability and safety of cyclosporine for microemulsion in the treatment of active rheumatoid arthritis. Open study]

Autor: J C, Marcos, A, Maccagno, E, Gutfraind, A, Garsd, D O, Messina, J, Maldonado Cocco, C, Battagliotti, C M, Onetti, G, Tate, H O, Venarotti, H, Grosman, E A, Díaz, A B, Otero

Publikováno v: Medicina. 60(4)

Cyclosporine for microemulsion has been widely used in the treatment of rheumatoid arthritis (RA) with remarkably good results over progression of joint damage, as reported by the GRISAR Study. A local group in Argentina, performed a prospective, ope

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::98f93649d1e4ea86eefb7ce6351b3a23
https://pubmed.ncbi.nlm.nih.gov/11188947

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy Multinational Study Group

Autor: C, Hawkey, L, Laine, T, Simon, A, Beaulieu, J, Maldonado-Cocco, E, Acevedo, A, Shahane, H, Quan, J, Bolognese, E, Mortensen

Publikováno v: Arthritis and rheumatism. 43(2)

This randomized, double-blind study tested the hypothesis that rofecoxib, a drug that specifically inhibits cyclooxygenase 2, would cause fewer gastroduodenal ulcers than ibuprofen (in a multicenter trial), and its side effects would be equivalent to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c41560fc6cf287ff0fa5053080f7933c
https://pubmed.ncbi.nlm.nih.gov/11079047

Zobrazit plný text záznamu

[Effect of diltiazem on cold-induced left ventricular dysfunction in patients with systemic sclerosis]

Autor: R H, Rey, G, Marrero, A, Chwojnik, J A, Martínez Martínez, J, Maldonado Cocco, S, Rodrigué, H, Casabé

Publikováno v: Medicina. 57(1)

Patients with systemic sclerosis (SS) have cardiac dysfunction induced by cold exposure. We and others have demonstrated this finding after corporal chilling, suggesting a "coronary Raynaud phenomenon" mediated by intermittent vascular spasm. In this

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d30f62c58ddfbde8e72594dc15094929
https://pubmed.ncbi.nlm.nih.gov/9435369

Zobrazit plný text záznamu

[Cold-induced cardiac abnormalities in systemic sclerosis]

Autor: R H, Rey, G, Marrero, A, Chwojnik, J, Martínez Martínez, J, Maldonado Cocco, S, Rodrigué, H, Casabé

Publikováno v: Medicina. 55(4)

Cardiac abnormalities are frequent in patients with systemic sclerosis (SS). These abnormalities have been demonstrated in over 80% of patients with SS and there are some clues that suggest that an intermittent vascular spasm (i.e. coronary Raynaud's

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::87ab27248a9f92a631ebac916c50d61a
https://pubmed.ncbi.nlm.nih.gov/8728866

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání